Search
for
Sort by
Research 421–450 of 1000+
- Old Wine in New Bottles: Reviving Old Therapies for Alopecia Areata Using Rodent Models
- The Effect of JAK Inhibitor on the Survival, Anagen Re-Entry, and Hair Follicle Immune Privilege Restoration in Human Dermal Papilla Cells
- Effects of mesenchymal stem cell therapy on alopecia areata in cellular and hair follicle organ culture models
- The Changing Landscape of Alopecia Areata: The Translational Landscape
- SOCS3 treatment prevents the development of alopecia areata by inhibiting CD8+ T cell-mediated autoimmune destruction
- Treatment of Alopecia Areata with Anti-Interferon-γ Antibodies
- Suppression of Vitamin D Receptor and Induction of Retinoid X Receptor α Expression During Squamous Differentiation of Cultured Keratinocytes
- Understanding the Role of Type I Interferons in Cutaneous Lupus and Dermatomyositis: Toward Better Therapeutics
- Skin disease is prevented but nephritis is accelerated by multiple pregnancies in autoimmune MRL/LPR mice
- Transcriptome Meta-Analysis Confirms the Hidradenitis Suppurativa Pathogenic Triad: Upregulated Inflammation, Altered Epithelial Organization, and Dysregulated Metabolic Signaling
- Induction of T cell exhaustion by JAK1/3 inhibition in the treatment of alopecia areata
- Failure to induce alopecia areata in C3H/HeJ mice with exogenous interferon gamma
- Th1/Th2 PB balance and CD200 expression of patients with active severe alopecia areata
- Hair follicle-derived mesenchymal stem cells decrease alopecia areata mouse hair loss and reduce inflammation around the hair follicle
- Antroquinonol Exerts Immunosuppressive Effect on CD8<sup>+</sup> T Cell Proliferation and Activation to Resist Depigmentation Induced by H<sub>2</sub>O<sub>2</sub>
- Translational Positioning of Janus Kinase (JAK) Inhibitors in Alopecia Areata
- Immunomodulators in the treatment of cutaneous lymphoma
- Exacerbation of alopecia areata during pegylated interferon alpha-2b and ribavirin therapy, possibly due to the collapse of hair follicle immune privilege
- Pathological Mechanisms Involved in Epidermolysis Bullosa Simplex: Current Knowledge and Therapeutic Perspectives
- T-cell “induced-self” MHC class I/peptide complexes may enable “de novo” tolerance induction to neo-antigens occurring outside of the thymus
- What is behind the ‘swarm of bees’ in alopecia areata
- Increased blood levels of NKG2D+CD4+ T cells in patients with alopecia areata
- Mathematical model for alopecia areata
- Photoprotective and immunoregulatory capacity of ginsenoside Rg1 in chronic ultraviolet B-irradiated BALB/c mouse skin
- Effects of cytokines, anti-cancer agents and cocarcinogen on DNA synthesis in hair bulb cells
- Pathophysiology of Alopecia Areata in the Pediatric Patient
- Decreased CD19+CD24hiCD38hi Regulatory B Cells in Alopecia Areata
- Engineering a New Mouse Model for Vitiligo
- Cytokines and growth factors influence hair growth in vitro. Possible implications for the pathogenesis and treatment of alopecia areata
- Rare and common manifestations of COVID‐19 in children